Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

HIV infects the body by attacking CD4 cells (a type of immune cell), inserting its genetic material, and replicating itself. PrEP medications contain antiretroviral drugs that interfere with this ...

Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...

Shahin Davoudpour, PhD, MA, MA, talked with Physician’s Weekly about using social network strategies to improve pre-exposure prophylaxis awareness and uptake.

Strategies that address population-specific concerns about medical mistrust and employ operational tactics, including staff ...

HIV prevention pills should be free, but insurers are still charging. Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment ...

Lenacapavir’s six-month protection makes it the longest-lasting type, an option that could attract people ... A recent study found states with high use of PrEP saw a decrease in HIV infections, while ...